What is Vonoprazan's Price?
The price of vonoprazan can vary depending on factors such as dosage, quantity, and geographic location. Information from DrugPatentWatch.com indicates that a 30-day supply of vonoprazan can range from $300 to $400. Specific pricing details may be available through pharmacies or healthcare providers.
How is Vonoprazan Priced and Reimbursed?
Vonoprazan's pricing is influenced by its status as a prescription medication. Reimbursement by insurance plans often depends on formulary coverage and any applicable copayments or deductibles. Patients may also have access to discount programs or coupons that can affect out-of-pocket costs.
When Will Vonoprazan Patents Expire?
Patent expiry dates for pharmaceuticals like vonoprazan are crucial for understanding potential generic competition and price changes. DrugPatentWatch.com tracks these patent statuses. The earliest expected patent expiry for vonoprazan is in 2027, with others extending further into the future, potentially into 2034 and beyond [1].
What is the Impact of Patent Expiry on Vonoprazan's Price?
Once patents expire, generic versions of vonoprazan can enter the market. This typically leads to a significant decrease in the drug's price due to increased competition. The availability of generics can make treatment more affordable for patients and healthcare systems.
Are There Generic Alternatives to Vonoprazan Now?
As of the most recent patent information, generic versions of vonoprazan are not yet available on the market because key patents are still in effect [1]. The introduction of generics will depend on the successful challenge or expiry of these patents.
How Does Vonoprazan Compare to Other Acid Reducers?
Vonoprazan is a potassium-competitive acid blocker (P-CAB), a different class of medication than proton pump inhibitors (PPIs) like omeprazole and lansoprazole. P-CABs work by reversibly inhibiting the H+/K+-ATPase in gastric parietal cells. Clinical studies have suggested that vonoprazan may offer faster and more sustained acid suppression compared to some PPIs, particularly in conditions like erosive esophagitis and for Helicobacter pylori eradication [2].
What is Vonoprazan Used For?
Vonoprazan is approved for the treatment of acid-related conditions. In Japan, it is indicated for erosive esophagitis, gastric ulcers, duodenal ulcers, reflux esophagitis, and as part of a regimen for Helicobacter pylori eradication [2]. It is also used for the prevention of ulcer recurrence during low-dose aspirin or NSAID administration [2].
What Are the Side Effects of Vonoprazan?
Common side effects reported with vonoprazan include constipation, diarrhea, nausea, abdominal pain, and headache [2]. Less common side effects may involve rash, increased liver enzymes, and changes in blood cell counts [2].
Who Manufactures Vonoprazan?
Vonoprazan is developed and manufactured by Takeda Pharmaceutical Company [2].
---
1. DrugPatentWatch.com. "Vonoprazan." Accessed [Date].
2. Takeda Pharmaceutical Company. "Takecab® (vonoprazan fumarate) Tablets." Accessed [Date].